Randomised double-blind comparison of lofexidine and clonidine in the out-patient treatment of opiate withdrawal.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 9649979.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study compares the clinical response to lofexidine and clonidine in the out-patient treatment of opiate withdrawal in 50 opiate addicts, using a randomised double-blind study design. Patients were taking 40 mg or less methadone daily, or equivalent amounts of other opiates. Fifty-eight percent of those starting treatment completed detoxification, and were opiate free at 4 weeks: more patients completed withdrawal in the lofexidine group, but the difference was not significant. Clonidine produced more hypotensive effects: more home visits were also required by medical staff. There was no other significant difference in side effects. Both drugs can be used successfully in out-patient detoxification, but lofexidine is more economical in regard to staff time.
Medical subject headings
- Adrenergic alpha-Agonists
- Clonidine
- Narcotic Antagonists
- Opioid-Related Disorders
- Substance Withdrawal Syndrome